143 related articles for article (PubMed ID: 8167744)
1. Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome.
Siminovitch KA; Greer WL; Axelsson B; Rubin LA; Novogrodsky A; Peacocke M
Immunodeficiency; 1993; 4(1-4):99-108. PubMed ID: 8167744
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation.
Greer WL; Higgins E; Sutherland DR; Novogrodsky A; Brockhausen I; Peacocke M; Rubin LA; Baker M; Dennis JW; Siminovitch KA
Biochem Cell Biol; 1989 Sep; 67(9):503-9. PubMed ID: 2803729
[TBL] [Abstract][Full Text] [Related]
4. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.
Piller F; Le Deist F; Weinberg KI; Parkman R; Fukuda M
J Exp Med; 1991 Jun; 173(6):1501-10. PubMed ID: 2033371
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
[TBL] [Abstract][Full Text] [Related]
6. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
Rosenstein Y; Park JK; Hahn WC; Rosen FS; Bierer BE; Burakoff SJ
Nature; 1991 Nov; 354(6350):233-5. PubMed ID: 1683685
[TBL] [Abstract][Full Text] [Related]
7. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
[TBL] [Abstract][Full Text] [Related]
8. CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytes.
Dragone L; Pallant A; Insel R; Frelinger JG
Exp Clin Immunogenet; 1992; 9(3):130-40. PubMed ID: 1338889
[TBL] [Abstract][Full Text] [Related]
9. Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome.
Khan S; Holding S; Doré PC; Sewell WA
Med Hypotheses; 2008; 70(2):269-72. PubMed ID: 17664047
[TBL] [Abstract][Full Text] [Related]
10. Sialophorin (CD43) and the Wiskott-Aldrich syndrome.
Remold-O'Donnell E; Rosen FS
Immunodefic Rev; 1990; 2(2):151-74. PubMed ID: 2223062
[TBL] [Abstract][Full Text] [Related]
11. Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43.
Axelsson B; Youseffi-Etemad R; Hammarström S; Perlmann P
J Immunol; 1988 Nov; 141(9):2912-7. PubMed ID: 3049818
[TBL] [Abstract][Full Text] [Related]
12. CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA.
Pallant A; Fukuda M; Frelinger JG
Eur J Immunol; 1990 Jul; 20(7):1423-8. PubMed ID: 2143724
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of CD43 and CDw60 on T cells from patients with atopic dermatitis.
Higashi N; Wu K; Grønhøj Larsen C; Deleuran M; Kawana S; Yamamoto K; Thestrup-Pedersen K
Acta Derm Venereol; 2001; 81(4):263-7. PubMed ID: 11720173
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of T-cell adhesion and activation by CD43.
Manjunath N; Correa M; Ardman M; Ardman B
Nature; 1995 Oct; 377(6549):535-8. PubMed ID: 7566153
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody.
Silverman LB; Wong RC; Remold-O'Donnell E; Vercelli D; Sancho J; Terhorst C; Rosen F; Geha R; Chatila T
J Immunol; 1989 Jun; 142(12):4194-200. PubMed ID: 2542404
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet calpain on normal T-lymphocyte CD43: hypothesis of events in the Wiskott-Aldrich syndrome.
Remold-O'Donnell E; Van Brocklyn J; Kenney DM
Blood; 1992 Apr; 79(7):1754-62. PubMed ID: 1558970
[TBL] [Abstract][Full Text] [Related]
17. MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation.
Alvarado M; Klassen C; Cerny J; Horejsí V; Schmidt RE
Eur J Immunol; 1995 Apr; 25(4):1051-5. PubMed ID: 7537669
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.
Shelley CS; Remold-O'Donnell E; Davis AE; Bruns GA; Rosen FS; Carroll MC; Whitehead AS
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2819-23. PubMed ID: 2784859
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.
Giordanengo V; Limouse M; Desroys du Roure L; Cottalorda J; Doglio A; Passeron A; Fuzibet JG; Lefebvre JC
Blood; 1995 Sep; 86(6):2302-11. PubMed ID: 7662977
[TBL] [Abstract][Full Text] [Related]
20. Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome.
Gerwin N; Friedrich C; Perez-Atayde A; Rosen FS; Gutierrez-Ramos JC
Clin Exp Immunol; 1996 Nov; 106(2):208-17. PubMed ID: 8918565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
